Bio-Path Holdings, Inc. (BPTH) vs ZyVersa Therapeutics, Inc. (ZVSA)

Bio-Path Holdings, Inc. and ZyVersa Therapeutics, Inc. are both Biotechnology companies. Bio-Path Holdings, Inc. is the larger, with a market value of $1.1M against $970.0K — 1.1× the size. Across the 7 metrics below, Bio-Path Holdings, Inc. leads on 4 and ZyVersa Therapeutics, Inc. on 3.

Valuation

Metric BPTH ZVSA Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.00 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield 0.00% (3,679.60%) (28.84%)
Free cash flow yield 0.00% (511.54%) (23.03%)

Profitability

Metric BPTH ZVSA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 157.01% 817.13% (57.72%)
Return on assets (605.50%) (225.42%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BPTH ZVSA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 87.75% 50.71% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BPTH ZVSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 0.05 4.73
Net debt to EBITDA 0.10 0.00 0.96

Dividend

Metric BPTH ZVSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric BPTH ZVSA Biotechnology median
Market cap 1.07m 970.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack